2021
DOI: 10.1016/j.canlet.2021.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 53 publications
0
7
0
Order By: Relevance
“…Moreover, the expression of LCK was positively correlated with the expression of PD-1, PD-L1 and CTLA4 ( Figure 10 A–C). However, some studies have shown that the high expression of PD-1/PD-L1 inhibits the sensitivity of HCC patients to ICIs [ 33 ], and some studies have shown that the high expression of PD-1/PD-L1 can be used as a benchmark for evaluating HCC immunotherapy [ 34 ]. Therefore, to further prove the influence of LCK expression on the response to immunotherapy, we used the MCP-counter algorithm to generate an immune score heatmap based on the differences in LCK expression in the TCGA data ( Figure 10 D,E); the results showed that the immune score of the group with high LCK expression was significantly higher than that of the group with low LCK expression, p < 0.05 (the higher the immune score, the higher the sensitivity of tumour patients to drugs).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Moreover, the expression of LCK was positively correlated with the expression of PD-1, PD-L1 and CTLA4 ( Figure 10 A–C). However, some studies have shown that the high expression of PD-1/PD-L1 inhibits the sensitivity of HCC patients to ICIs [ 33 ], and some studies have shown that the high expression of PD-1/PD-L1 can be used as a benchmark for evaluating HCC immunotherapy [ 34 ]. Therefore, to further prove the influence of LCK expression on the response to immunotherapy, we used the MCP-counter algorithm to generate an immune score heatmap based on the differences in LCK expression in the TCGA data ( Figure 10 D,E); the results showed that the immune score of the group with high LCK expression was significantly higher than that of the group with low LCK expression, p < 0.05 (the higher the immune score, the higher the sensitivity of tumour patients to drugs).…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, ICIs can indirectly activate TLSs by blocking the PD-1/PD-L1 pathway and thereby activate the expression of immune cells, thus, enhancing the anti-tumour effect [ 58 ]. For example, nivolumab and pembrolizumab treat advanced liver cancer by reducing the expression of PD-1 and thereby decreasing T cell depletion [ 33 ]. In addition, high expression of PD-L1 can increase the level of AFP in the blood of HCC patients, thus, promoting tumour progression [ 59 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…24 It belonged to the Src kinase family and had a hand in signal transduction downstream of many cell surface receptors, 24 the phosphorylation of it on T cell receptors was a key step in the establishment and connection of signals in the process of T cell activation. 25 Besides, LCK has been covered that it express highly in a great majority of tumors, such as breast cancer, 26,27 nasopharyngeal carcinoma 28 and glioma. 29 In addition to leukemia, some solid tumors have been treated with pan-Src family kinase inhibitors, such as dasatinib and saracatinib, both of which are effective in inhibiting tumor growth.…”
Section: Discussionmentioning
confidence: 99%
“…The most common pathological type of NPC is non-keratinizing carcinoma with a high degree of malignancy, metastasis, and proliferative ability [ 5 ]. The onset of NPC is hard to detect, so early diagnosis is rare, and NPC has often already progressed into middle or late stage by the time it is detected [ 6 ]. While radiotherapy and chemotherapy can effectively control the growth of local tumors, local recurrence and distant metastasis contribute to the low survival rate of patients with NPC [ 7 ].…”
Section: Introductionmentioning
confidence: 99%